Cargando…

The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study

BACKGROUND: Biologicals, such as anti-tumor necrosis factor (anti-TNF), reduce cardiovascular disease (CVD) in patients with inflammatory rheumatic diseases. Impaired renal function is a known predictor of CVD and elevated in ankylosing spondylitis (AS). OBJECTIVE: To assess the effect of anti-TNF o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swart, I. A. P., Visman, I. M., Heslinga, M., van der Horst-Bruinsma, I. E., van Denderen, J. C., Nurmohamed, M. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652256/ https://www.ncbi.nlm.nih.gov/pubmed/35962246 http://dx.doi.org/10.1007/s10067-022-06330-9

Ejemplares similares

Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation
por: Baniaamam, M., et al.
Publicado: (2021)

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
por: Heslinga, SC, et al.
Publicado: (2018)

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
por: Heslinga, Sjoerd C, et al.
Publicado: (2015)

The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients—The CARDAS Study
por: Baniaamam, Milad, et al.
Publicado: (2021)

Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis
por: van Weely, Salima FE, et al.
Publicado: (2012)

Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography
por: de Vries, Mirjam K., et al.
Publicado: (2010)

The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis
por: van den Oever, I. A. M., et al.
Publicado: (2020)

Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010)

Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited
por: Bron, Johannes L., et al.
Publicado: (2009)

Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study
por: Bruijnen, Stefan TG, et al.
Publicado: (2012)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review
por: van der Weijden, M. A. C., et al.
Publicado: (2012)

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by (18)F-fluoride positron emission tomography
por: Bruijnen, Stefan T G, et al.
Publicado: (2018)

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by (18)F-fluoride positron emission tomography
por: Bruijnen, Stefan T G, et al.
Publicado: (2018)

Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice
por: Rusman, Tamara, et al.
Publicado: (2018)

Patient with ankylosing spondylitis and scleroderma renal crisis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2018)

Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study
por: Maas, Fiona, et al.
Publicado: (2015)

Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis
por: Dai, Qinghong, et al.
Publicado: (2022)

Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction
por: Baraliakos, X, et al.
Publicado: (2016)

[(18)F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography
por: de Jongh, Jerney, et al.
Publicado: (2022)

A prospective clinical investigation of the effects of anti-TNF alpha therapy on exercise capacity in patients with ankylosing spondylitis
por: ÇAPKIN, Erhan, et al.
Publicado: (2019)

The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study
por: Baniaamam, Milad, et al.
Publicado: (2020)

Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
por: Batko, Bogdan, et al.
Publicado: (2018)

Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
por: Coşkun, Belkıs Nihan, et al.
Publicado: (2022)

Advances in managing ankylosing spondylitis
por: Daikh, David I., et al.
Publicado: (2014)

A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
por: van der Horst-Bruinsma, Irene, et al.
Publicado: (2021)

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
por: Ramiro, Sofia, et al.
Publicado: (2013)

Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice
por: Liu, Bin, et al.
Publicado: (2019)

Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis
por: Qian, Hongyan, et al.
Publicado: (2020)

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Soós, Boglárka, et al.
Publicado: (2022)

Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy
por: TÜRK, Sümeyye Merve, et al.
Publicado: (2021)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Harmonization, data management, and statistical issues related to prospective multicenter studies in Ankylosing spondylitis (AS): Experience from the Prospective Study Of Ankylosing Spondylitis (PSOAS) cohort
por: Rahbar, Mohammad H., et al.
Publicado: (2018)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register
por: Lord, Paul A. C., et al.
Publicado: (2010)

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study
por: Webers, Casper, et al.
Publicado: (2018)

Anti-TNF Therapy Regulates Phagosome Pathway by Inhibiting NCF4 Expression to Treat Ankylosing Spondylitis
por: Liu, Sha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sa9kn09tp96hjqs0r88clm55ie